AzTrials
AzTrials

Small Bowel ObstructionSBOCUSNCT05864378

POCUS for Small Bowel Obstruction in the ED: a Retrospective Study

An observational study of Small Bowel Obstruction and Point of Care Ultrasound, run by Azienda Ospedaliero-Universitaria di Modena.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study protocol aims to evaluate the impact of point-of-care ultrasound (POCUS) on the diagnosis and management of small bowel obstruction (SBO) in the emergency department (ED). SBO is a potentially life-threatening condition that requires prompt diagnosis and management. Read more about this study

Who is it for?
Ages 18 years and older
How many people
230 participants
Where
No sites listed yet
Study dates
1 Sep 2023to 1 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will be divided into two groups: 1. The POCUS group: patients who were evaluated by ED physicians who perform POCUS intestinal loops examination as part of their clinical practice 2. The non-POCUS group: patients who were evaluated by ED physicians who do not perform POCUS intestinal loops examination for any reason.

Who may be able to join

  • Age > 18 years old
  • Clinical suspicion of SBO based on history and physical examination
  • Plain abdominal radiography (AXR) or CT scan performed in the ED

Who cannot join

  • Pregnancy
  • Known bowel obstruction
  • Previous abdominal surgery within 30 days
  • Refusal or inability to consent

Trial locations and contacts

No sites are listed yet.

Carmine Cristiano Di Gioia contact

+39 3493812503

cristianodigioia@icloud.com

About this study

Official title: The Impact of Point-of-care Ultrasound on the Diagnosis and Management of Small Bowel Obstruction in the Emergency Department: a Retrospective Observational Single-center Study

This study protocol aims to evaluate the impact of point-of-care ultrasound (POCUS) on the diagnosis and management of small bowel obstruction (SBO) in the emergency department (ED). SBO is a potentially life-threatening condition that requires prompt diagnosis and management. Currently, the diagnosis of SBO is based on clinical evaluation and imaging tests, including plain abdominal radiography and computed tomography (CT) scan. POCUS is a bedside imaging technique that is rapid, non-invasive, repeatable, cost-effective and radiation-free, and can provide valuable information for the diagnosis and management of SBO. The primary objective of this study is to compare the time to diagnosis of SBO between patients who undergo POCUS intestinal loops examination and those who do not undergo POCUS in the ED. The secondary objectives include comparing the hospital length of stay, the rate of surgical intervention, the rate of complications, and the mortality rate between the two groups. This is a monocentric retrospective cohort study that will include all adult patients (> 18 years old) who presented to the ED with suspected SBO. The study population will be divided into two groups: the POCUS group and the non-POCUS group. The sample size calculation will be based on the assumption of a 30% reduction in the time to diagnosis of SBO in the POCUS group compared to the non-POCUS group, with a power of 80%. The results of this study may provide more robust evidence on the diagnostic accuracy and impact of POCUS for SBO in the ED.

Keywords
POCUS, SBO

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05864378
Study groupRoleWhat they receive
The POCUS groupPatients who were evaluated by ED physicians who perform POCUS intestinal loops examination as part of their clinical practice
The non-POCUS groupPatients who were evaluated by ED physicians who do not perform POCUS intestinal loops examination for any reason

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to diagnosis of SBO by POCUS or CT scan

    The primary outcome will be the time to diagnosis of SBO by POCUS or CT scan, defined as the interval between the ED arrival and the confirmation of SBO by either imaging modality, comparing the two groups.

    Measured: All patients will be seen by the emergency physician within 6 hours of admission to the emergency department.

Secondary outcomes (4)
  1. The hospital length of stay

    The interval between the ED arrival and the hospital discharge

    Measured: Patients will be followed up for a maximum of 2 months from admission to the emergency department, until discharge or death.

  2. The rate of surgical intervention

    The proportion of patients who underwent laparotomy or laparoscopy for SBO

    Measured: Patients will be followed up for a maximum of 2 months from admission to the emergency department, until discharge or death.

  3. The rate of complications

    The proportion of patients who developed bowel ischemia, perforation, peritonitis or sepsis during their hospitalization

    Measured: Patients will be followed up for a maximum of 2 months from admission to the emergency department, until discharge or death.

  4. The mortality rate

    The proportion of patients who died during their hospitalization or within 30 days after their ED arrival

    Measured: Patients will be followed up for a maximum of 2 months from admission to the emergency department, until discharge or death.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 May 2023
  2. Study start1 Sep 2023 (estimated)
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion1 Feb 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
230 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05864378
Sponsor's protocol ID
SBOCUS2023
Acronym
SBOCUS
Status last verified
May 2023
First submitted
9 May 2023
Last updated
18 May 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Small Bowel Obstruction and Point of Care Ultrasound, run by Azienda Ospedaliero-Universitaria di Modena.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 May 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Carmine Cristiano Di Gioia (+39 3493812503, cristianodigioia@icloud.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to diagnosis of SBO by POCUS or CT scan (time frame: All patients will be seen by the emergency physician within 6 hours of admission to the emergency department.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2023; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in